Staedtisches Klinikum Braunschweig

Braunschweig 38126 DE

1 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Crohn Disease, Metastatic Castration-resistant Prostate Neoplasms, Myelodysplastic Syndromes, Urinary Bladder Neoplasms

Studies at this site

• A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder — Running, not enrolling
• A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder — Completed
• Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML — Completed